Week of March 1st, 2021 | Vol. 10, Issue 9
In This Issue
Featured Headlines
Recent Industry Transactions
Industry Trading Comps
Recent Industry Headlines
Market Reports
Upcoming Events

Quick Links

Contact Information
Managing Director
Business Development

Managing Director
Head of M&A and Capital Advisory

Above is an overview of recent industry M&A activity. For additional information, see the charts below or click on the chart above to download complete transaction tables broken out by industry sub sectors.

For more information about our consumer healthcare JV with The Emerson Group, Daybreak Consumer Care, click here.
Recent Materials Providing Insight Into Healthcare Related Industries
Current M&A Pipeline
Representative Current Retained Sell-Side And Partnering Opportunities
Project Trident
Buy-side | Generic Pharma | Manufacturing liquid generics

Project Aspen
Sell-side | CDMO | Multinational CDMO headquartered in US

Project Athena
Sell-side / Licensing | Medical Device | Novel device for pelvic organ prolapse

Project Bulldog
Sell-side | Pharma Services| Life sciences consulting firm
Pharmaceutical Associates, Inc. (PAI) today announced the appointment of Domenic Ciarico as Chief Commercial Officer, bringing with him 25 years of industry experience to the company. In his new role, Ciarico will oversee PAI’s growth strategy, further solidifying the company’s position as the number one manufacturer of quality liquid pharmaceuticals in the United States.

Ciarico, a multi-business unit leader with 25-years of healthcare industry experience, previously worked at Par Pharmaceutical where he served as Executive Vice President and Chief Commercial Officer of their Generic and Sterile division. Prior to joining Par, Ciarico served as Senior Vice President of Health Systems for AmerisourceBergen, leading the health systems commercial team and directly managing commercial strategy and sales activity for Health Systems customer portfolio valued at over $17 billion in annual net sales.

An Overview of Transactions Within Market Sub-segments
Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.
Pharma & Biotech
17 transactions totaling $3,865 million
Supplies, Equipment & Services
20 transactions totaling $1,339 million
Healthcare IT & Managed Care
8 transactions totaling $12 million
Healthcare Facilities & Distributors
8 transactions totaling $72 million
Pharma & Biotech
46 transactions totaling $1,764 million
Supplies, Equipment & Services
24 transactions totaling $491 million
Healthcare IT & Managed Care
14 transactions totaling $487 million
Healthcare Facilities & Distributors
4 transactions totaling $5 million
Pharma & Biotech
31 transactions totaling $2,420 million
Supplies, Equipment & Services
8 transactions totaling $1,196 million
Healthcare IT & Managed Care
2 transactions totaling $15 million
Healthcare Facilities & Distributors
0 transactions
A Breakdown of Relevant Trading Multiples
Each week, we provide updated trading comps for leading companies from numerous healthcare sub-sectors.
To the right you will see a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

For a complete trading comp analysis (including the individual equities that comprise the sub sectors), click on the table. 

Note: data reflects prior week close.
A Sampling of Relevant Industry Headlines from Last Week
Below are snippets from relevant industry news articles from the past week. For additional information or the article's complete text, click the headline link to view the original publication.
February 26, 2021 - Fierce Biotech
Neurostimulation developer Axonics Modulation Technologies has acquired Contura, makers of a hydrogel-based injection to help treat stress urinary incontinence, for a combination of cash and stock totaling $200 million. 

February 26, 2021 - Fierce Pharma
Catalent locked in a deal to buy 100% of the shares of Delphi Genetics, a plasmid DNA cell and gene therapy CDMO based out of Gosselies, Belgium. The move will help speed the start of commercial plasmid manufacturing at Catalent's facility in Rockville, Maryland, and add to the CDMO's fast-growing hub in Gosselies. 

February 26, 2021 - Fierce Biotech
Silicon’s platform for generating small-molecule drugs is powered by a proprietary supercomputing cluster and custom hardware for simulating interactions at the atomic level—as well as integrated medicinal chemistry laboratories—which Roivant hopes to wield to bolster its own efforts in the field of targeted protein degradation, powered by VantAI’s deep learning research.

February 26, 2021 - Fierce Pharma
The FDA has made it official, allowing the COVID-19 vaccine from Pfizer-BioNTech to be stored at typical pharmaceutical freezer temperatures for up to two weeks. The move will simplify delivery of the vaccine.
Welcome to Bourne, let's talk.

Since our founding in 2001, Bourne Partners has remained focused on fulfilling the unique needs of established, middle-market healthcare and pharmaceutical companies across the globe. Our track record includes advising middle market companies in healthcare M&A assignments totaling more than $7 billion, and growing companies into successful and well-positioned pharmaceutical enterprises.